摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙基-4H-1,2,4-噻唑-3-硫醇 | 27105-98-2

中文名称
4-乙基-4H-1,2,4-噻唑-3-硫醇
中文别名
——
英文名称
4-ethyl-2,3-dihydro-4H-1,2,4-triazole-3-thione
英文别名
4-ethyl-2,4-dihydro-[1,2,4]triazole-3-thione;4-Aethyl-2,4-dihydro-[1,2,4]triazol-3-thion;4-Ethyl-1,2,4-triazolin-5-thion;4-ethyl-4H-1,2,4-triazole-3-thiol;4-ethyl-1H-1,2,4-triazole-5-thione
4-乙基-4H-1,2,4-噻唑-3-硫醇化学式
CAS
27105-98-2
化学式
C4H7N3S
mdl
MFCD00185955
分子量
129.186
InChiKey
VYCYFQLHLFRVKW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    158.0±23.0 °C(Predicted)
  • 密度:
    1.34±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    8
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    59.7
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090
  • WGK Germany:
    3
  • 储存条件:
    2-8°C

SDS

SDS:0dfadec221c53a0b36732522fa669f8d
查看

反应信息

  • 作为反应物:
    描述:
    4-乙基-4H-1,2,4-噻唑-3-硫醇溴乙酸甲酯potassium carbonate 作用下, 以 丙酮 为溶剂, 反应 12.0h, 以83%的产率得到methyl 2-((4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetate
    参考文献:
    名称:
    二芳基甲烷骨架的系统构效关系 (SAR) 探索和高效新型尿酸转运蛋白 1 (URAT1) 抑制剂的发现
    摘要:
    为了系统地探索和更好地理解二芳基甲烷骨架在设计强效尿酸转运蛋白 1 (URAT1) 抑制剂时的构效关系 (SAR),设计并合成了 33 种化合物(1a-1x 和 1ha-1hi),并测定了它们的体外 URAT1 抑制活性 (IC50)。三轮系统的 SAR 探索导致发现了一种高效的新型 URAT1 抑制剂,1h,其效力分别比母体 lesinurad 和苯溴马隆强 200 倍和 8 倍(IC50 = 0.035 μM 对人 URAT1 1 小时 vs lesinurad 和苯溴马隆分别为 7.18 μM 和 0.28 μM)。化合物 1h 是迄今为止我们实验室发现的最有效的 URAT1 抑制剂,也可与目前正在临床试验中开发的最有效的抑制剂相媲美。
    DOI:
    10.3390/molecules23020252
  • 作为产物:
    描述:
    异硫氰酸乙酯potassium carbonate 作用下, 以 为溶剂, 反应 16.25h, 生成 4-乙基-4H-1,2,4-噻唑-3-硫醇
    参考文献:
    名称:
    Narrow SAR in odorant sensing Orco receptor agonists
    摘要:
    The systematic exploration of a series of triazole-based agonists of the cation channel insect odorant receptor is reported. The structure-activity relationships of independent sections of the molecules are examined. Very small changes to the compound structure were found to exert a large impact on compound activity. Optimal substitutions were combined using a 'mix-and-match' strategy to produce best-in-class compounds that are capable of potently agonizing odorant receptor activity and may form the basis for the identification of a new mode of insect behavior modification. (C) 2014 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2014.04.081
点击查看最新优质反应信息

文献信息

  • Structure-activity relationships of triazole-benzodioxine inhibitors of cathepsin X
    作者:Urša Pečar Fonović、Damijan Knez、Martina Hrast、Nace Zidar、Matic Proj、Stanislav Gobec、Janko Kos
    DOI:10.1016/j.ejmech.2020.112218
    日期:2020.5
    Cathepsin X is a cysteine carboxypeptidase that is involved in various physiological and pathological processes. In particular, highly elevated expression and activity of cathepsin X has been observed in cancers and neurodegenerative diseases. Previously, we identified compound Z9 (1-(2,3-dihydrobenzo [b][1,4]dioxin-6-yl)-2-((4-isopropyl-4H-1,2,4-triazol-3-yl)thio)ethan-1-one) as a potent and specific reversible cathepsin X inhibitor. Here, we have explored the effects of chemical variations to Z9 of either benzodioxine or triazol moieties, and the importance of the central ketomethylenethio linker. The ketomethylenethio linker was crucial for cathepsin X inhibition, whereas changes of the triazole heterocycle did not alter the inhibitory potencies to a greater extent. Replacement of benzodioxine moiety with substituted benzenes reduced cathepsin X inhibition. Overall, several synthesized compounds showed similar or improved inhibitory potencies against cathepsin X compared to Z9, with IC50 values of 7.1 mu M-13.6 mu M. Additionally, 25 inhibited prostate cancer cell migration by 21%, which is under the control of cathepsin X. (c) 2020 Published by Elsevier Masson SAS.
  • Dobosz, Maria; Pitucha, Monika; Wujec, Monika, Acta poloniae pharmaceutica, 1996, vol. 53, # 1, p. 31 - 38
    作者:Dobosz, Maria、Pitucha, Monika、Wujec, Monika
    DOI:——
    日期:——
  • Freund, Chemische Berichte, 1896, vol. 29, p. 2487
    作者:Freund
    DOI:——
    日期:——
  • Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor
    作者:Wenqing Cai、Jingwei Wu、Wei Liu、Yafei Xie、Yuqiang Liu、Shuo Zhang、Weiren Xu、Lida Tang、Jianwu Wang、Guilong Zhao
    DOI:10.3390/molecules23020252
    日期:——
    In order to systematically explore and better understand the structure-activity relationship (SAR) of a diarylmethane backbone in the design of potent uric acid transporter 1 (URAT1) inhibitors, 33 compounds (1a–1x and 1ha–1hi) were designed and synthesized, and their in vitro URAT1 inhibitory activities (IC50) were determined. The three-round systematic SAR exploration led to the discovery of a highly
    为了系统地探索和更好地理解二芳基甲烷骨架在设计强效尿酸转运蛋白 1 (URAT1) 抑制剂时的构效关系 (SAR),设计并合成了 33 种化合物(1a-1x 和 1ha-1hi),并测定了它们的体外 URAT1 抑制活性 (IC50)。三轮系统的 SAR 探索导致发现了一种高效的新型 URAT1 抑制剂,1h,其效力分别比母体 lesinurad 和苯溴马隆强 200 倍和 8 倍(IC50 = 0.035 μM 对人 URAT1 1 小时 vs lesinurad 和苯溴马隆分别为 7.18 μM 和 0.28 μM)。化合物 1h 是迄今为止我们实验室发现的最有效的 URAT1 抑制剂,也可与目前正在临床试验中开发的最有效的抑制剂相媲美。
  • Narrow SAR in odorant sensing Orco receptor agonists
    作者:Ian M. Romaine、Robert W. Taylor、Samsudeen P. Saidu、Kwangho Kim、Gary A. Sulikowski、Laurence J. Zwiebel、Alex G. Waterson
    DOI:10.1016/j.bmcl.2014.04.081
    日期:2014.6
    The systematic exploration of a series of triazole-based agonists of the cation channel insect odorant receptor is reported. The structure-activity relationships of independent sections of the molecules are examined. Very small changes to the compound structure were found to exert a large impact on compound activity. Optimal substitutions were combined using a 'mix-and-match' strategy to produce best-in-class compounds that are capable of potently agonizing odorant receptor activity and may form the basis for the identification of a new mode of insect behavior modification. (C) 2014 Elsevier Ltd. All rights reserved.
查看更多

同类化合物

伊莫拉明 (5aS,6R,9S,9aR)-5a,6,7,8,9,9a-六氢-6,11,11-三甲基-2-(2,3,4,5,6-五氟苯基)-6,9-甲基-4H-[1,2,4]三唑[3,4-c][1,4]苯并恶嗪四氟硼酸酯 (5-氨基-1,3,4-噻二唑-2-基)甲醇 齐墩果-2,12-二烯[2,3-d]异恶唑-28-酸 黄曲霉毒素H1 高效液相卡套柱 非昔硝唑 非布索坦杂质Z19 非布索坦杂质T 非布索坦杂质K 非布索坦杂质E 非布索坦杂质67 非布索坦杂质65 非布索坦杂质64 非布索坦杂质61 非布索坦代谢物67M-4 非布索坦代谢物67M-2 非布索坦代谢物 67M-1 非布索坦-D9 非布索坦 非唑拉明 雷西纳德杂质H 雷西纳德 阿西司特 阿莫奈韦 阿米苯唑 阿米特罗13C2,15N2 阿瑞匹坦杂质 阿格列扎 阿扎司特 阿尔吡登 阿塔鲁伦中间体 阿培利司N-1 阿哌沙班杂质26 阿哌沙班杂质15 阿可替尼 阿作莫兰 阿佐塞米 镁(2+)(Z)-4'-羟基-3'-甲氧基肉桂酸酯 锌1,2-二甲基咪唑二氯化物 铵2-(4-氯苯基)苯并恶唑-5-丙酸盐 铬酸钠[-氯-3-[(5-二氢-3-甲基-5-氧代-1-苯基-1H-吡唑-4-基)偶氮]-2-羟基苯磺酸基][4-[(3,5-二氯-2-羟基苯 铁(2+)乙二酸酯-3-甲氧基苯胺(1:1:2) 钠5-苯基-4,5-二氢吡唑-1-羧酸酯 钠3-[2-(2-壬基-4,5-二氢-1H-咪唑-1-基)乙氧基]丙酸酯 钠3-(2H-苯并三唑-2-基)-5-仲-丁基-4-羟基苯磺酸酯 钠(2R,4aR,6R,7R,7aS)-6-(2-溴-9-氧代-6-苯基-4,9-二氢-3H-咪唑并[1,2-a]嘌呤-3-基)-7-羟基四氢-4H-呋喃并[3,2-D][1,3,2]二氧杂环己膦烷e-2-硫醇2-氧化物 野麦枯 野燕枯 醋甲唑胺